Dr. Paul Gurbel, MD
Dr. Paul Gurbel, MD
About
Dr. Paul Gurbel, MD is
Patients said this doctor explains conditions well.
Patients said this doctor is trustworthy.
Patients said the staff was friendly.
Patients said scheduling was easy.
Compare with other Cardiology Specialists







Experience and Background Check
Insurance Accepted
-
APCN Open Access Aetna SelectChoice Plus POS IIElect Choice (Open Access) EPOManaged Choice (Open Access) POSOpen Choice PPOPremier Care Network APCN Choice (OAMC) POS IISelectSmall Group Maryland Elect Choice Open AccessSmall Group Maryland HMO
-
Blue Card PPO
-
Cigna PPOLocalPlusOpen Access Plus
-
First Health (Coventry Health Care) PPO
-
BCBS PPOCommunity Blue PPOPPOBlue PPO
-
Choice Care Network PPOChoice Care PPOChoice POS
-
MVP Health Plan EPO
-
Choice Plus POSMD IPA/Optimum Choice HMO/Preferred POS HMO-POSMedica ChoiceNavigate HMONavigate POSNexus Open AccessOptions PPO
Locations
-
Greenspring Valley Cardiovascular Associates - Quarry Lake2700 Quarry Lake Dr Ste 240, Baltimore, MD 21209
Patient Satisfaction
Leave a review
How likely are you to recommend Dr. Gurbel?
I've seen Dr Gurbel since he saved my heart muscle with a Stent in 2011. He is a great Dr and treats you like a friend. I would recommend him him to anyone.

Claim my profile
About Me
- As the director of the Center for Thrombosis Research at Sinai Hospital of Baltimore (SCTR), Paul A. Gurbel, M.D.'s research has sparked a much needed debate in the cardiology community surrounding the under-recognized role that platelets play in coronary thrombosis and the efficacy of conventional antiplatelet treatment. His translational research has influenced treatment guidelines and the design of prospective large scale clinical trials.A major focus of his laboratory is new drug development, for which his Center has received NIH funding. Within the Center is a dedicated phase I facility, where first-in-human and early phase studies are conducted. His Center has worked closely with private industry to develop new antiplatelet agents, and has played a pivotal role in the development of two recently approved antiplatelet agents (prasugrel and ticagrelor) indicated for the treatment of ACS. Dr. Gurbel's current research is focused on further understanding how genotype and various aspects of platelet function should be used to optimally identify the patient with high cardiovascular risk.Over the past decade, numerous advances in the treatment of patients with coronary artery disease have been made that were influenced by the discoveries made by Dr. Gurbel and his research team. Dr. Gurbel instituted the field of personalized antiplatelet therapy in the era of dual antiplatelet therapy (DAPT) by demonstrating:1.The presence of antiplatelet response variability to clopidogrel.2.The role that clopidogrel and aspirin dose have on pharmacodynamics.3.The key link between high platelet reactivity to adenosine diphosphate and post-stenting ischemic risk in patients on DAPT.4.The key link between a threshold of platelet reactivity to ischemic event occurrence.5.The relation that gender, ethnicity and age have with platelet reactivity.6.The effect that genetic polymorphisms and drug-drug interactions have on antiplatelet pharmacodynamics and clinical outcomes in patients with cardiovascular disease.7.The relation between heightened platelet reactivity, hypercoagulability, inflammation, and clinical disease state acuity.Dr. Gurbel earned his medical degree at the University of Maryland School of Medicine and completed an internship and residency in Internal Medicine at Duke University Medical Center in Durham, North Carolina. Dr. Gurbel then completed a fellowship in Pulmonary and Critical Care at Johns Hopkins University, followed by fellowships in Cardiovascular Disease and Interventional Cardiology, as well as a chief residency in Internal Medicine at Duke. He is board-certified in internal medicine, cardiovascular disease, and interventional cardiology by the American Board of Internal Medicine. In addition to prolific research, Dr. Gurbel remains one of the busiest cardiac interventionalist's on the east coast. In 2011, Dr. Gurbel was recognized by the US News World Report, The Washington Post Magazine, Best Doctors, and other agencies as being one of the best physicians in America.Dr. Gurbel serves on the editorial boards for several journals, including the Journal of the American College of Cardiology and the Journal of the Royal Society of Medicine Cardiovascular Disease and on the Scientific Session Committee for Transcatheter Cardiovascular Therapeutics and the International Scientific Advisory Board, International Society of Thrombosis and Haemostasis. In addition to book chapters and monographs, he has authored nearly 300 articles in peer-reviewed journals, most recently including JAMA, Circulation, Journal of the American College of Cardiology, Diabetes, American Journal of Cardiology, American Heart Journal, Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Platelets, and Journal of Interventional Cardiology. In 2012 he authored 30 manuscripts in the peer-reviewed literature. In 2012, three peer reviewed papers developed by Dr. Gurbel and his team were named Most Important Papers in Antiplatelet Therapy by
- Dr. Paul Gurbel, MD is a cardiology specialist in Baltimore, MD and has over 39 years of experience in the medical field. They graduated from LOYOLA COLLEGE OF MARYLAND in 1983. They specialize in Cardiology.
Education
-
LOYOLA COLLEGE OF MARYLAND
1983
Board Certifications
- Cardiovascular Disease, Interventional Cardiology and Internal Medicine
Frequently Asked Questions
Find contact information here to make an appointment.
A list of accepted insurance providers is available on the Sharecare insurance check. It is always a good idea to verify your insurance when making an appointment.
New patients are generally accepted by Dr. Paul Gurbel, MD. To arrange an appointment, call the number on Dr. Gurbel's profile.
Dr. Gurbel in specializes in Cardiology. See more on Sharecare.
Dr. Gurbel frequently treats the following conditions: Rheumatic Tricuspid Disease, Pulmonary Hypertension and Chronic Pulmonary Heart Diseases (incl. Pulmonary Hypertension). See more on Sharecare.
Dr. Gurbel's office is located at 2700 Quarry Lake Dr Ste 240 Baltimore, MD 21209. You can find other locations and directions on Sharecare.
Dr. Gurbel provides telehealth services. Please contact the office to determine whether you are eligible.
Dr. Paul Gurbel, MD is affiliated with Sinai Hospital of Baltimore.
Yes, Dr. Paul Gurbel, MD holds board certification in Cardiovascular Disease, Interventional Cardiology and Internal Medicine.
Dr. Paul Gurbel, MD has a star rating of 5.0/5. See more patient feedback on Sharecare.
Hospital Affiliations
-
Sinai Hospital of Baltimore
2401 W Belvedere Ave, Baltimore, MD